Evidence map›Paper›PMID 34032140›Full record

ArticleJournal of the American Heart Association2021

Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population-Based Study.

Seyedmohammad Saadatagah, Ahmed K Pasha, Lubna Alhalabi, Harigopal Sandhyavenu, Medhat Farwati, Carin Y Smith, Christina M Wood-Wentz, Kent R Bailey, Iftikhar J Kullo

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Seyedmohammad SaadatagahDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.
Ahmed K PashaDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.
Lubna AlhalabiDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.
Harigopal SandhyavenuDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.
Medhat FarwatiDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.
Carin Y SmithDivision of Clinical Trials and Biostatistics Mayo Clinic Rochester MN.
Christina M Wood-WentzDivision of Clinical Trials and Biostatistics Mayo Clinic Rochester MN.
Kent R BaileyDivision of Clinical Trials and Biostatistics Mayo Clinic Rochester MN.
Iftikhar J KulloDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.
Mayo Clinic · USMayo Clinic in Arizona · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
EHR-Based Strategies to Improve Outcomes in Familial HypercholesterolemiaR01HL135879 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2017 to 2020
$2.5M
Patient-Oriented Research in Genomic Discovery and ImplementationK24HL137010 · NHLBI · MAYO CLINIC ROCHESTER · PI KULLO, IFTIKHAR J · 2017 to 2021
$590k
NHLBI NIH HHS K24 HL137010NHLBI NIH HHS R01 HL135879NIA NIH HHS R01 AG034676
6 · The paper itself

Abstract

Background Hypertriglyceridemia is associated with increased risk of coronary heart disease but the association is often attributed to concomitant metabolic abnormalities. We investigated the epidemiology of primary isolated hypertriglyceridemia (PIH) and associated cardiovascular risk in a population-based setting. Methods and Results We identified adults with at least one triglyceride level ≥500 mg/dL between 1998 and 2015 in Olmsted County, Minnesota. We also identified age- and sex-matched controls with triglyceride levels <150 mg/dL. There were 3329 individuals with elevated triglyceride levels; after excluding those with concomitant hypercholesterolemia, a secondary cause of high triglycerides, age <18 years or an incomplete record, 517 patients (49.4±14.0 years, 72.0% men) had PIH (triglyceride 627.6±183.6 mg/dL). The age- and sex-adjusted prevalence of PIH in adults was 0.80% (0.72-0.87); the diagnosis was recorded in 60%, 46% were on a lipid-lowering medication for primary prevention and a triglyceride level <150 mg/dL was achieved in 24.1%. The association of PIH with coronary heart disease was attenuated but remained significant after adjustment for demographic, socioeconomic, and conventional cardiovascular risk factors (hazard ratio [HR], 1.53; 95% CI, 1.06-2.20;

Indexed as

Population SurveillanceBiomarkersCoronary DiseaseFemaleHumansHypertriglyceridemiaIncidenceMaleMiddle AgedMinnesotaPrognosisRetrospective StudiesRisk AssessmentRisk FactorsTriglyceridesBiomarkersTriglyceridescoronary heart diseaseepidemiologyhypertriglyceridemia

Identifiers

PMID34032140
PMCPMC8483538
OpenAlexW3164070937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.